- Home
- FORR vs SGHT Comparison
FORR vs SGHT Comparison
Compare FORR & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- SGHT
- Stock Information
- Founded
- FORR 1983
- SGHT 2011
- Country
- FORR United States
- SGHT United States
- Employees
- FORR N/A
- SGHT N/A
- Industry
- FORR Diversified Commercial Services
- SGHT Medical Specialities
- Sector
- FORR Consumer Discretionary
- SGHT Health Care
- Exchange
- FORR Nasdaq
- SGHT Nasdaq
- Market Cap
- FORR 193.5M
- SGHT 179.7M
- IPO Year
- FORR 1996
- SGHT 2021
- Fundamental
- Price
- FORR $9.44
- SGHT $3.50
- Analyst Decision
- FORR
- SGHT Buy
- Analyst Count
- FORR 0
- SGHT 8
- Target Price
- FORR N/A
- SGHT $3.87
- AVG Volume (30 Days)
- FORR 71.9K
- SGHT 163.3K
- Earning Date
- FORR 07-31-2025
- SGHT 07-31-2025
- Dividend Yield
- FORR N/A
- SGHT N/A
- EPS Growth
- FORR N/A
- SGHT N/A
- EPS
- FORR N/A
- SGHT N/A
- Revenue
- FORR $422,269,000.00
- SGHT $78,109,000.00
- Revenue This Year
- FORR N/A
- SGHT N/A
- Revenue Next Year
- FORR $2.04
- SGHT $11.22
- P/E Ratio
- FORR N/A
- SGHT N/A
- Revenue Growth
- FORR N/A
- SGHT N/A
- 52 Week Low
- FORR $8.50
- SGHT $2.03
- 52 Week High
- FORR $20.62
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- FORR 41.42
- SGHT 43.79
- Support Level
- FORR $9.47
- SGHT $3.34
- Resistance Level
- FORR $10.00
- SGHT $3.65
- Average True Range (ATR)
- FORR 0.41
- SGHT 0.25
- MACD
- FORR -0.07
- SGHT -0.06
- Stochastic Oscillator
- FORR 7.52
- SGHT 18.27
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.